Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof
CA 2090620 A1 · Owner: Mathews, William R. · Inventors: Hamlyn, John M.; Mandel, Frederick; Ducharme, Donald W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods for diagnosing pre-hypertension hypertension, congestive, cardiomyopathy renal failure, salt-sensitivity and adenomas and endocrine cell hyperplasias are disclosed. Also disclosed are methods for monitoring hypertension therapy congestive, cardiomyopathy therapy, renal failure therapy and adenoma and endocrine cell hyperplasia therapy. These methods involve using an antibody having binding specificity to ouabain to immunologically measure the level of human ouabain in body fluid or tissue of a subject. Additionally methods for treating a hypertensive subject by inducing passive or active immunity to human ouabain in the subject are disclosed, along with an antibody having binding …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 21, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.